Literature DB >> 8699555

Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study.

J J Osterwalder1.   

Abstract

BACKGROUND: Naloxone is standard medication for the treatment of heroin intoxications. No large-scale studies have yet been carried out to determine its toxicity in heroin intoxications.
METHODS: We have undertaken an investigation as to the frequency, type and degree of severity of complications attributable to naloxone administration. Subjects treated between 1991 and 1993 with naloxone for intravenous drug intoxications were prospectively evaluated. MAIN OUTCOME MEASUREMENTS: Development of ventricular tachycardia or fibrillation; atrial fibrillation; asystole; pulmonary edema; convulsions; vomiting; and violent behavior within ten minutes after parenteral administration of naloxone.
RESULTS: Six of 453 intoxicated subjects (1.3%; 95% confidence interval 0.4%-3%) suffered severe adverse effects within ten minutes after naloxone administration (one asystole; three generalized convulsions; one pulmonary edema; and one violent behavior). After the ten minute period, no further complications were observed.
CONCLUSIONS: The short time between naloxone administration and the occurrence of complications, as well as the type of complications, are strong evidence of a causal link. In 1000 clinically diagnosed intoxications with heroin or heroin mixtures, from 4 to 30 serious complications can be expected. Such a high incidence of complications is unacceptable and could theoretically be reduced by artificial respiration with a bag valve device (hyperventilation) as well as by administering naloxone in minimal divided doses, injected slowly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699555     DOI: 10.3109/15563659609013811

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  26 in total

1.  Take home naloxone for opiate addicts. Drug misusers may benefit from training in cardiopulmonary resuscitation.

Authors:  C A Graham; G W McNaughton; A J Ireland; K Cassells
Journal:  BMJ       Date:  2001-10-20

Review 2.  Strategies for preventing heroin overdose.

Authors:  Karl A Sporer
Journal:  BMJ       Date:  2003-02-22

Review 3.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

Review 4.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 5.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

6.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

Review 7.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

8.  Management of drug abuse emergencies.

Authors:  J A Henry
Journal:  J Accid Emerg Med       Date:  1996-11

Review 9.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

10.  Predictors of Delayed Postoperative Respiratory Depression Assessed from Naloxone Administration.

Authors:  Toby N Weingarten; Vitaly Herasevich; Maria C McGlinch; Nicole C Beatty; Erin D Christensen; Susan K Hannifan; Amy E Koenig; Justin Klanke; Xun Zhu; Bhargavi Gali; Darrell R Schroeder; Juraj Sprung
Journal:  Anesth Analg       Date:  2015-08       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.